Updates in Surgery

, Volume 70, Issue 1, pp 121–127 | Cite as

Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression

  • Misbah Khan
  • Aamir Ali Syed
  • Amina Iqbal Khan
  • Syed Raza Hussain
  • Namra Urooj
Original Article

Abstract

Locoregional recurrence is common in papillary thyroid cancer PTC and an optimal surgical treatment with respect to the multifocal nature of the disease stays controversial. It is a retrospective analytical study design. 209 diagnosed PTCs managed at our institute were grouped into macro-PTC with a size of dominant focus >1 cm (unifocal n = 106 and multifocal n = 64) and micro-PTMC if size of all foci was <1 cm; (unifocal n = 16 and multifocal PTMC n = 23). The primary endpoint is recurrence and tumor free survival in each of the four groups. Secondary endpoint is an assessment of a benefit of completion total thyroidectomy in terms of assignment of true focal status to an individual’s PTC. The median follow-up was 4.1 years. Upon completion thyroidectomy, the tumor focality changed to multifocal in 31.4% of macro-PTC and 60% of micro-PTMC. Multifocality was an independent risk factor for recurrence, OR 2.41 for macro (CI 1.14–5.11), and 3.48 for micro-multifocal PTMC (CI 1.19–10.2). Disease free survival patterns on Kaplan–Meier’s plots were alike for micro- and macro-unifocal groups, and similarly stayed comparable among the two multifocal groups. Our analysis showed that tumor multifocality rather than size is the significant factor determining prognosis; hence, total thyroidectomy is indicated for an optimal assessment of true focality in micro-PTC.

Keywords

Multifocal papillary Thyroid cancer Micro-papillary thyroid cancer Tumor recurrence Recurrence free survival 

Notes

Acknowledgements

The authors thank Dr. Farhana Badar, clinical research scientist for her help in the statistical analysis and Dr. Sana Syed Assistant Professor of Neurology at Tufts Medical Center and Clinical Translational Research Fellow at Pfizer for the help in draft editing.

Compliance with ethical standards

Source of funding

This research did not receive any grant for its conduction or completion by any source.

Conflict of interest

The Authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. The authors alone are responsible for the content and writing of the paper.

Research involving human participants and/or animals

This study does not involve any kind of animal related contacts or experiments by any of the listed authors.

Informed consent

The requirement for informed consent for this study was waived off by the Institution review board, due to it’s retrospective nature, data anonymization and no direct contact with the study subjects.

References

  1. 1.
    Ning Qu, Ling Z, Qing-hai J, Yong-xue Z, Zhuo-ying W, Qiang S, Yu W et al (2014) Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer 14(1):914CrossRefGoogle Scholar
  2. 2.
    Nixon IJ, Shaha AR, Patel SG (2014) Surgical diagnosis: frozen section and the extent of surgery. Otolaryngol Clin North Am Erica 47(4):519–528CrossRefGoogle Scholar
  3. 3.
    Schonberger J, Marienhagen J, Agha A, Rozeboom S, Bachmeier E, Schlitt H et al (2007) Papillary microcarcinoma and papillary cancer of the thyroid ≤1 cm: modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46:115–120PubMedGoogle Scholar
  4. 4.
    Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL (2009) Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 20(10):1728–1735CrossRefPubMedGoogle Scholar
  5. 5.
    Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–987 (discussion 987–988) CrossRefPubMedGoogle Scholar
  6. 6.
    Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K et al (2008) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28(11):1115–1121CrossRefGoogle Scholar
  7. 7.
    Wang W, Wang H, Teng X, Wang H, Mao C, Teng R et al (2010) Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol 41:1299–1309CrossRefPubMedGoogle Scholar
  8. 8.
    Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37(2):376–384CrossRefPubMedGoogle Scholar
  9. 9.
    Zhou Y-L, Gao E, Zhang W, Han Y, Gui-Long G, Xiao-Hua Z et al (2012) Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol 10:67CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK et al (2015) Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Head Neck 37(5):650–654CrossRefPubMedGoogle Scholar
  11. 11.
    Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98(1):31–40CrossRefPubMedGoogle Scholar
  12. 12.
    Riss JC, Peyrottes I, Chamorey E, Haudebourg J, Sudaka A, Benisvy D et al (2012) Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. Eur Ann Otorhinolaryngol Head Neck Dis 129(4):175–178CrossRefPubMedGoogle Scholar
  13. 13.
    Kim KJ, Kim SM, Lee YS, Chung WY, Chang HS, Park CS (2015) Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2309 consecutive patients. Ann Surg Oncol 22(1):125–131CrossRefPubMedGoogle Scholar
  14. 14.
    Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMedGoogle Scholar
  15. 15.
    Mantinan B, Rego-Iraeta A, Larrañaga A, Fluiters E, Sánchez-Sobrino P, Garcia-Mayor RV (2012) Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res 2012:469397CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hassan A, Razi M, Riaz S, Khalid M, Nawaz MK, Syed AA et al (2016) Survival analysis of papillary thyroid carcinoma in relation to stage and recurrence risk: a 20-year experience in Pakistan. Clin Nucl Med 41(8):606–613CrossRefPubMedGoogle Scholar
  17. 17.
    Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716CrossRefPubMedGoogle Scholar
  18. 18.
    Kuo SF, Lin SF, Chao TC, Hsueh C, Lin KJ, Lin JD (2013) Prognosis of multifocal papillary thyroid carcinoma. Int J Endocrinol 2013:809382CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Connor MP, Wells D, Schmalbach CE (2011) Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg 144(2):210–215CrossRefPubMedGoogle Scholar
  21. 21.
    Khan M, Syed AA, Khan AI, Syed RH, Zafar W (2015) Morbidity comparison of primary and completion total thyroidectomy for differentiated thyroid cancer in relation to the extent of redo surgery. Int J Surg Open 1:14–17. doi: 10.1016/j.ijso.2016.02.003 CrossRefGoogle Scholar
  22. 22.
    Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS et al (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19(10):1043–1048CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Surgery (SIC) 2017

Authors and Affiliations

  1. 1.Department of Surgical OncologyShaukat Khanum Memorial Cancer Hospital and Research Centre, SKMCH & RCLahorePakistan

Personalised recommendations